Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 278-

  Chretien, F ^a   Gray, F ^a   De Truchis, P ^a   Belec, L ^a   Levy, Y ^a   Dubreuil Lemaire, M L ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

EID: 0030026843     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.278     Document Type: Letter

References (0)